Kesimpta is administered as a subcutaneous injection, meaning it's injected under the skin. Patients can use a pre-filled Sensoready pen or pre-filled syringe to self-administer the medication at home. The initial dosing involves weekly injections for the first three weeks (Weeks 0, 1, and 2), followed by monthly injections starting at Week 4. This dosing schedule helps to establish the medication's effects quickly and maintain them over time.